Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Crowther

Showing results (231-240 of 286) with videos related to

Pageof 29
Sort By:
Thrombosis and Haemostasis|June 12, 2010
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort studyGrégoire Le Gal, Michael J Kovacs, Marc Carrier, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 19, 2019
Semi-automatic measurement of intracranial hemorrhage growth on non-contrast CTKevin J Chung, Hulin Kuang, Alyssa Federico, et al.
Archives of Internal Medicine|September 10, 2008
Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT studyJames Douketis, Deborah Cook, Maureen Meade, et al.
BMC Medical Research Methodology|May 14, 2020
Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guideMatthew Ventresca, Holger J Schünemann, Fergus Macbeth, et al.
Critical Care (London, England)|March 5, 2008
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factorsDeborah Cook, James Douketis, Maureen Meade, et al.
Journal of Thrombosis and Thrombolysis|May 17, 2022
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forumGeoffrey D Barnes, Allison Burnett, Arthur Allen, et al.
British Journal of Haematology|April 27, 2011
Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolismMarc A Rodger, Natasha Kekre, Grégoire Le Gal, et al.
JAMA|January 13, 2016
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical TrialChristine H Lee, Theodore Steiner, Elaine O Petrof, et al.
Trials|March 2, 2011
Conservative management versus open reduction and internal fixation for mid-shaft clavicle fractures in adults--the Clavicle Trial: study protocol for a multicentre randomized controlled trialUmile Giuseppe Longo, Sughran Banerjee, Julie Barber, et al.
Medicine|September 11, 2015
Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill PatientsGuowei Li, Deborah J Cook, Mitchell A H Levine, et al.
Pageof 29

Showing results (231-240 of 286) with videos related to

Sort By:
Pageof 29
Thrombosis and Haemostasis|June 12, 2010
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort studyGrégoire Le Gal, Michael J Kovacs, Marc Carrier, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 19, 2019
Semi-automatic measurement of intracranial hemorrhage growth on non-contrast CTKevin J Chung, Hulin Kuang, Alyssa Federico, et al.
Archives of Internal Medicine|September 10, 2008
Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT studyJames Douketis, Deborah Cook, Maureen Meade, et al.
BMC Medical Research Methodology|May 14, 2020
Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guideMatthew Ventresca, Holger J Schünemann, Fergus Macbeth, et al.
Critical Care (London, England)|March 5, 2008
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factorsDeborah Cook, James Douketis, Maureen Meade, et al.
Journal of Thrombosis and Thrombolysis|May 17, 2022
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forumGeoffrey D Barnes, Allison Burnett, Arthur Allen, et al.
British Journal of Haematology|April 27, 2011
Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolismMarc A Rodger, Natasha Kekre, Grégoire Le Gal, et al.
JAMA|January 13, 2016
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical TrialChristine H Lee, Theodore Steiner, Elaine O Petrof, et al.
Trials|March 2, 2011
Conservative management versus open reduction and internal fixation for mid-shaft clavicle fractures in adults--the Clavicle Trial: study protocol for a multicentre randomized controlled trialUmile Giuseppe Longo, Sughran Banerjee, Julie Barber, et al.
Medicine|September 11, 2015
Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill PatientsGuowei Li, Deborah J Cook, Mitchell A H Levine, et al.
Pageof 29